CA2577597A1 - Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor - Google Patents

Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor Download PDF

Info

Publication number
CA2577597A1
CA2577597A1 CA002577597A CA2577597A CA2577597A1 CA 2577597 A1 CA2577597 A1 CA 2577597A1 CA 002577597 A CA002577597 A CA 002577597A CA 2577597 A CA2577597 A CA 2577597A CA 2577597 A1 CA2577597 A1 CA 2577597A1
Authority
CA
Canada
Prior art keywords
bsx
immunogenic
protein
antibody
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002577597A
Other languages
English (en)
French (fr)
Inventor
James A. Mackintosh
Robert Alan Cole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteome Systems Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2577597A1 publication Critical patent/CA2577597A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002577597A 2004-08-19 2005-08-19 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor Abandoned CA2577597A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60324304P 2004-08-19 2004-08-19
US60/603,243 2004-08-19
PCT/AU2005/001254 WO2006017912A1 (en) 2004-08-19 2005-08-19 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor

Publications (1)

Publication Number Publication Date
CA2577597A1 true CA2577597A1 (en) 2006-02-23

Family

ID=35907183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002577597A Abandoned CA2577597A1 (en) 2004-08-19 2005-08-19 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor

Country Status (7)

Country Link
US (1) US20090011426A1 (https=)
EP (1) EP1794187A4 (https=)
JP (1) JP2008515388A (https=)
CN (1) CN101044160A (https=)
AU (1) AU2005274615A1 (https=)
CA (1) CA2577597A1 (https=)
WO (1) WO2006017912A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102713629B (zh) * 2009-11-20 2016-02-24 俄勒冈健康科学大学 用于检测结核分枝杆菌感染的方法
US20130243801A1 (en) * 2010-08-23 2013-09-19 New York University Epitope therapy for infectious diseases
EP2812704A4 (en) 2012-02-07 2016-03-23 Intuitive Biosciences Inc MYCOBACTERIUM STUBERCULOSIS-SPECIFIC PEPTIDES FOR DETECTING INFECTION OR IMMUNIZATION OF NON-MUSCLE PRIMATES
AR094791A1 (es) * 2013-02-14 2015-08-26 Univ Arkansas Composiciones y métodos para mejorar las respuestas inmunes ante una infección por eimeria o para limitar una infección por eimeria
GB201315748D0 (en) 2013-09-04 2013-10-16 Imp Innovations Ltd Biological methods and materials for use therein
US9940652B1 (en) * 2014-08-11 2018-04-10 Robert James Cole Restrictively exchanging and controlling vehicular data between communication devices of a private network
CN105181837A (zh) * 2015-08-28 2015-12-23 程永娟 一种结核分枝杆菌检测方法
GB201700487D0 (en) * 2017-01-11 2017-02-22 Hermon-Taylor John Diagnostic
US11238504B2 (en) * 2018-04-09 2022-02-01 Robert James Cole Systems and methods for restrictively exchanging and controlling product data between communication devices of a private network
CN109765379B (zh) * 2018-12-19 2021-11-23 南华大学 结核分枝杆菌蛋白的应用
CN115112897B (zh) * 2021-12-10 2024-11-01 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法
CN114874297A (zh) * 2022-04-26 2022-08-09 广东省结核病控制中心 一种结核分枝杆菌蛋白组、其筛选方法及其应用
CN117323442B (zh) * 2023-08-30 2024-05-03 广东医科大学 一种巨噬细胞靶向二氧化锰纳米系统的制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465633B1 (en) * 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
WO2003093307A2 (en) * 2002-04-27 2003-11-13 The Secretary Of State For Environment, Food And Rural Affairs Mycobacterial antigens and uses thereof

Also Published As

Publication number Publication date
AU2005274615A1 (en) 2006-02-23
CN101044160A (zh) 2007-09-26
EP1794187A4 (en) 2008-03-26
EP1794187A1 (en) 2007-06-13
JP2008515388A (ja) 2008-05-15
WO2006017912A1 (en) 2006-02-23
US20090011426A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
US20110268744A1 (en) Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
US8298778B2 (en) Method and kit for detecting antibody to avibacterium paragallinarum
JP2008530037A (ja) 表面に位置したＳｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅのポリペプチド
US20090011426A1 (en) Methods of Diagnosis and Treatment of M.Tuberculosis Infection and Reagents Therefor
CA2604855C (en) Ehrlichia canis diva (differentiate infected from vaccinated animals)
WO2008119358A2 (en) Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
US7169393B2 (en) Antigenic peptide fragments of VapA protein, and uses thereof
WO2007131293A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vi
US7807182B2 (en) Early detection of mycobacterial disease using peptides
WO2003012395A2 (en) Early detection of mycobacterial disease using peptides
US20110212133A1 (en) Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor
JP2008501625A (ja) 表在Ｃａｍｐｙｌｏｂａｃｔｅｒｊｅｊｕｎｉポリペプチド
Bannantine et al. Identification of two Mycobacterium avium subspecies paratuberculosis gene products differentially recognised by sera from rabbits immunised with live mycobacteria but not heat-killed mycobacteria
EP0879244A1 (en) Mycoplasma recombinant polypeptide vaccines
WO2006000045A1 (en) Novel methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor i
WO2007140545A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
WO2007131291A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
JP2003501013A (ja) ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用
JP2004512851A (ja) ラウソニア種による感染を処置する新規な治療用組成物
WO2007131292A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor xi
US20030138868A1 (en) Agents and method for diagnosing lyme disease and borreliosis vaccine
WO2007087679A1 (en) Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v
MX2010009516A (es) Secuencias novedosas de brachyspira, composiciones inmunogenicas, metodos para la preparacion y usos de las mismas.
AU2005256177A1 (en) Novel methods of diagnosis of treatment of P. aeruginosa infection and reagents therefor
AU1064797A (en) Mycoplasma recombinant polypeptides and vaccines

Legal Events

Date Code Title Description
FZDE Discontinued